Back

Estimated impact of timely guidelines-based initiation of dual-combination anti-hypertensive therapy on long-term cardiovascular outcomes in a population of 1.4 million individuals.

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Challenges in hypertension management Pharmacotherapy ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Professor Antonio Coca

Hospital Clinic, University of Barcelona, Barcelona (Spain)

4 More presentations in this session

Presentation thumbnail
State-of-the-art lecture on pharmacotherapy in hypertension
Professor A. Pathak (Luxembourg, LU)
Slides Video
Presentation thumbnail
Effect of initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy on ambulatory blood pressure indices
Doctor J. Nolde (Freiburg, DE)
Abstract Slides Video
Presentation thumbnail
Association of hydrochlorothiazide treatment compared to alternative diuretics with overall and skin cancer risk: a propensity-matched cohort study
Doctor F. Goetzinger (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Evening anti-hypertensive dosing, blood pressure and cardiovascular events in hypertensive: Updated meta-analysis of 41 trials in 65,271 patients
Doctor A. Sunjaya (Jakarta, ID)
Abstract Slides Video

Access the full session

Session thumbnail
Challenges in hypertension management
Video

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
The floor is yours: bring your questions about optimal blood pressure control for organ protection - expert panel
thumbnail
Congress Presentation
Hypertension, diabetes, and the kidney: a triple threat for adverse cardiovascular events?
thumbnail
Congress Presentation
Hypertension and glucose

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources